Tandem Diabetes Care (TNDM) Income from Continuing Operations (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Income from Continuing Operations came in at 20400000.0 in Q1 2026, up 84.38% YoY from 11064119.6 in Q1 2025, and down 3656.91% on a QoQ basis from 543000.0 in Q4 2025.
Tandem Diabetes Care (TNDM) Income from Continuing Operations (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Income from Continuing Operations data on file, last reported at 20400000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 84.38% year-over-year to 20400000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 94530000.0 (up 48.59% YoY) and the FY2025 annual result came in at 204710000.0, down 113.18% from the prior year.
- Income from Continuing Operations declined to 20400000.0 in Q1 2026, from 543000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 755000.0 in Q4 2024 to a low of 130600000.0 in Q1 2025.
- A 5-year average of 37549117.65 and a median of 29967000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations tumbled 951.88% — and 2024, when it soared 102.52%.
- Tracing TNDM's Income from Continuing Operations over 5 years: stood at 15891000.0 in 2022, then plunged by 88.58% to 29967000.0 in 2023, then surged by 102.52% to 755000.0 in 2024, then sank by 171.92% to 543000.0 in 2025, then slumped by 3656.91% to 20400000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 20400000.0 (Q1 2026), 543000.0 (Q4 2025), and 21165000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | -21.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.21 Mn |
| Mar 31, 2026 | -20.40 Mn |
| Dec 31, 2025 | -543,000.00 |
| Sep 30, 2025 | -21.17 Mn |
| Jun 30, 2025 | -52.42 Mn |
| Mar 31, 2025 | -130.60 Mn |
| Dec 31, 2024 | 755,000.00 |
| Sep 30, 2024 | -23.21 Mn |
| Jun 30, 2024 | -30.81 Mn |
| Mar 31, 2024 | -42.73 Mn |
| Dec 31, 2023 | -29.97 Mn |
| Sep 30, 2023 | -32.96 Mn |
| Jun 30, 2023 | -35.75 Mn |
| Mar 31, 2023 | -123.90 Mn |
| Dec 31, 2022 | -15.89 Mn |
| Sep 30, 2022 | -48.95 Mn |
| Jun 30, 2022 | -15.05 Mn |
| Mar 31, 2022 | -14.74 Mn |
| Dec 31, 2021 | 10.76 Mn |
| Sep 30, 2021 | 5.75 Mn |